These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 38609055)
1. Construction and validation of a nomogram for predicting remission of migraine patients with patent foramen ovale after closure. Wang Y; Lou Y; Chen Y; Shi J; Zhang H Int J Cardiol; 2024 Jul; 407():132026. PubMed ID: 38609055 [TBL] [Abstract][Full Text] [Related]
2. A Nomogram for the Prediction of Cessation of Migraine Among Patients With Patent Foramen Ovale After Percutaneous Closure. Zhao E; Xie H; Zhang Y Front Neurol; 2020; 11():593074. PubMed ID: 33193059 [No Abstract] [Full Text] [Related]
3. Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt. Biasco L; Infantino V; Orzan F; Vicentini S; Rovera C; Longo G; Chinaglia A; Belli R; Allais G; Gaita F J Cardiol; 2014 Nov; 64(5):390-4. PubMed ID: 24713153 [TBL] [Abstract][Full Text] [Related]
4. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial. Tobis JM; Charles A; Silberstein SD; Sorensen S; Maini B; Horwitz PA; Gurley JC J Am Coll Cardiol; 2017 Dec; 70(22):2766-2774. PubMed ID: 29191325 [TBL] [Abstract][Full Text] [Related]
5. Analysis of Risk Factors Related to the Efficacy of Foramen Ovale Closure as a Therapy for Migraine. Tang YJ; Su G; Zhang WW; Li Q; Bai R; Liu H Int Heart J; 2023 Mar; 64(1):28-35. PubMed ID: 36682764 [TBL] [Abstract][Full Text] [Related]
6. Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism. Wahl A; Praz F; Tai T; Findling O; Walpoth N; Nedeltchev K; Schwerzmann M; Windecker S; Mattle HP; Meier B Heart; 2010 Jun; 96(12):967-73. PubMed ID: 20538672 [TBL] [Abstract][Full Text] [Related]
7. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature. Manolis AS Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032 [TBL] [Abstract][Full Text] [Related]
8. [Identification of potential influencing factors associated with elimination of migraine headache in patients with PFO after percutaneous closure]. Zhao EF; Xie H; Zhang YS Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jun; 51(6):656-661. PubMed ID: 37312485 [No Abstract] [Full Text] [Related]
9. Efficacy of patent foramen ovale closure for treating migraine: a prospective follow-up study. Qi Y; Zhang Y; Luo X; Cheng G; Du Y; Liu R; Xie H; Cheng Y; Guo Y; Luo G J Investig Med; 2021 Jan; 69(1):7-12. PubMed ID: 32928904 [TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of randomized trials on percutaneous patent foramen ovale closure for prevention of migraine. Elbadawi A; Barssoum K; Abuzaid AS; Rezq A; Biniwale N; Alotaki E; Mohamed AH; Vuyyala S; Ogunbayo GO; Saad M Acta Cardiol; 2019 Apr; 74(2):124-129. PubMed ID: 29914296 [TBL] [Abstract][Full Text] [Related]
11. Frequency of migraine headache relief following patent foramen ovale "closure" despite residual right-to-left shunt. Jesurum JT; Fuller CJ; Kim CJ; Krabill KA; Spencer MP; Olsen JV; Likosky WH; Reisman M Am J Cardiol; 2008 Oct; 102(7):916-20. PubMed ID: 18805122 [TBL] [Abstract][Full Text] [Related]
12. Impact of right-to-left shunt and transcatheter closure on the clinical features of migraine. He Q; Zhang Y; Wang F; Li C; Guo R; Li X; Luan B; Zhao H; Meng L; Chen H; Meng L Int J Neurosci; 2020 Mar; 130(3):270-275. PubMed ID: 31549584 [No Abstract] [Full Text] [Related]
13. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism. Rigatelli G; Dell'Avvocata F; Ronco F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Rigatelli G; Chen JP JACC Cardiovasc Interv; 2010 Mar; 3(3):282-7. PubMed ID: 20298985 [TBL] [Abstract][Full Text] [Related]
14. Changes in cerebral autoregulation, stroke-related blood biomarkers, and autonomic regulation after patent foramen ovale closure in severe migraine patients. Guo ZN; Qu Y; Gao Y; Xing Y; Ma H; Liu J; Guo YZ; Chang J; Zhang P; Jin H; Sun X; Han K; Hu HH; He Q; Simpson DM; Yang Y CNS Neurosci Ther; 2023 Oct; 29(10):3031-3042. PubMed ID: 37157233 [TBL] [Abstract][Full Text] [Related]
16. Improvement of migraine after patent foramen ovale percutaneous closure in patients with subclinical brain lesions: a case-control study. Vigna C; Marchese N; Inchingolo V; Giannatempo GM; Pacilli MA; Di Viesti P; Impagliatelli M; Natali R; Russo A; Fanelli R; Loperfido F JACC Cardiovasc Interv; 2009 Feb; 2(2):107-13. PubMed ID: 19463410 [TBL] [Abstract][Full Text] [Related]
17. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. Mattle HP; Evers S; Hildick-Smith D; Becker WJ; Baumgartner H; Chataway J; Gawel M; Göbel H; Heinze A; Horlick E; Malik I; Ray S; Zermansky A; Findling O; Windecker S; Meier B Eur Heart J; 2016 Jul; 37(26):2029-36. PubMed ID: 26908949 [TBL] [Abstract][Full Text] [Related]
18. PFO and Migraine: Is There a Role for Closure? Rayhill M; Burch R Curr Neurol Neurosci Rep; 2017 Mar; 17(3):20. PubMed ID: 28283958 [TBL] [Abstract][Full Text] [Related]
19. A Nomogram for Predicting Patent Foramen Ovale-Related Stroke Recurrence. Wu Z; Zhang C; Liu N; Xie W; Yang J; Guo H; Chi J Front Neurol; 2022; 13():903789. PubMed ID: 35756923 [TBL] [Abstract][Full Text] [Related]
20. Transcatheter Patent Foramen Ovale Closure Is Effective in Alleviating Migraine in a 5-Year Follow-Up. He YD; Yan XL; Qin C; Zhang P; Guo ZN; Yang Y Front Neurol; 2019; 10():1224. PubMed ID: 31803135 [No Abstract] [Full Text] [Related] [Next] [New Search]